Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women

Kim, Suk Chul; Messing, Susan; Shah, Krupa; Luque, Amneris E.

doi:10.1155/2013/784718

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women

Published Date:

Dec 18 2013

Publisher's site:

http://dx.doi.org/10.1155/2013/784718 New Site Icon

Source:

Infect Dis Obstet Gynecol. 2013; 2013.

[PDF-601.91 KB]

Details:

Personal Authors:

Kim, Suk Chul ; Messing, Susan ; Shah, Krupa ; Luque, Amneris E. ;

Keywords:

[+]

Pubmed ID:

24453469

Pubmed Central ID:

PMC3878554

Description:

More HIV-infected women are reaching older age and menopause, but there is limited information on cervical squamous intraepithelial lesions (SILs) on these women.|To assess the effect of HAART and menopause on SILs in HIV-infected women, we reviewed the results of Papanicolaou (Pap) tests obtained between 1991 and 2011 on 245 women. Progression to SILs was determined by comparing Pap test results. The association of HAART and transition to menopause on SILs was assessed using survival analysis.|Women receiving HAART had a 52% reduced risk in the progression to SILs compared to women receiving any other antiretroviral regimen or no regimen (CI: 0.33-0.70, P = 0.0001). A greater increase of CD4(+) cell counts was associated with a greater reduction on the risk of progression to SILs. Menopausal women had a 70% higher risk of progression to SILs than premenopausal women (CI: 1.11-2.62, P < 0.0001), adjusting for HIV medications, CD4(+) count, duration of HIV infection, moderation effect of menopause by age, prior IV drug use, and smoking.|HAART had a positive long-term effect on the progression to SILs. However, being younger and menopausal increases the risk of progression.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

P30 AI078498/AI/NIAID NIH HHS/United States
UL1 PR024160/PR/OCPHP CDC HHS/United States

Supporting Files:

	IDOG2013-784718.001.gif	image/gif
	IDOG2013-784718.001.jpg	image/jpeg
	IDOG2013-784718.002.gif	image/gif
	IDOG2013-784718.002.jpg	image/jpeg
	IDOG2013-784718.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children; recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics

Personal Author:

Danner, Susie P.; Dominguez, Kenneth L.; Mofenson, Lynne M.; Nesheim, Steven R.;

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). American Academy of Pediatrics. Centers for Disease Control and Prevention (U.S.). HIV Medicine Association. National Institutes of Health (U.S.). Pediatric Infectious Diseases Society.

Published:

September 4, 2009

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2009; 58(RR-11):1-166.

Series:

Morbidity and mortality weekly report. Recommendations and reports ; v. 58, no. RR-11
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 58, no. RR-11

Description:

This report updates and combines into one document earlier versions of guidelines for preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected children, last published in 2002 and 2004, respectively. These guidelines ...

Status:

superseded

File Type:

[PDF - 2.08 MB]
HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy

Personal Author:

Imai, Kentaro; Sutton, Madeline Y.; Mdodo, Rennatus; del Rio, Carlos;

Published:

Dec 19 2013

Source:

Obstet Gynecol Int. 2013; 2013.

Description:

More than half of persons living with HIV infection in the United States (U.S.) will be ≥50 years of age by 2020, including postmenopausal women. We conducted a systematic literature review about the effects of (1) HIV infection on age at menopause...

File Type:

[PDF - 761.50 KB]
Treating opportunistic infections among HIV-infected adults and adolescents; recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America

Personal Author:

Benson, Constance A.; Kaplan, Jonathan E.; Masur, Henry; Pau, Alice; Holmes, King K.;

Corporate Author:

Centers for Disease Control and Prevention (U.S.). HIV Medicine Association. Infectious Diseases Society of America. National Center for HIV, STD and TB Prevention (U.S.). National Institutes of Health (U.S.).

Published:

December 17, 2004

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 53, no. RR-15
Clinical infectious diseases ; v. 40, suppl. 3

Description:

"The National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, and CDC have developed guidelines for treatment of opportunistic infections (OIs) among adults and adolescents infected with human immunod...

File Type:

[PDF - 1.85 MB]
Treating opportunistic infections among HIV-exposed and infected children; recommendations from the Ceters for Disease Control and Prevention, the National Institutes of Health, and the Infectious Diseases Society of America

Personal Author:

Mofenson, Lynne M.

Corporate Author:

Centers for Disease Control and Prevention (U.S.). Infectious Diseases Society of America. National Center for HIV, STD and TB Prevention (U.S.). National Institutes of Health (U.S.).

Published:

December 3, 2004

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 53, no. RR-14
Clinical infectious diseases ; v. 40, suppl. 1

Description:

"In 2001, CDC, the National Institutes of Health, and the Infectious Diseases Society of America convened a working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opportunistic infections to serve as a compan...

File Type:

[PDF - 742.29 KB]
2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus; November 28, 2001

Corporate Author:

Centers for Disease Control and Prevention (U.S.). United States, Public Health Service.. Infectious Diseases Society of America.

Published:

November 28, 2001

Description:

NPIN 22737: This guideline lists each opportunistic infection and provides information on primary and secondary infection, prevention of exposure, and treatment recommendations as well as criteria for discontinuation of treatment. It covers Pneumocys...

File Type:

[PDF - 831.52 KB]